Koa Shoji Holdings (9273) Fundamentals 2026 — P/E 8.8x, Revenue Analysis | SniperIQ
Koa Shoji Holdings (9273) is a JP-listed Healthcare company in Drug Manufacturers - Specialty & Generic with a market capitalization of ¥32.9B, trading at ¥780.00 on the JPX. This SniperIQ fundamentals page covers Koa Shoji Holdings's valuation (P/E 8.8x, P/B 1.1x), profitability (net margin 15.6%), revenue (¥23.3B in FY2024), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Koa Shoji Holdings's market cap?
Koa Shoji Holdings (9273) has a market capitalization of approximately ¥32.9B, trading at ¥780.00 on the JPX. Market cap moves with the live share price.
What is Koa Shoji Holdings's P/E ratio?
Koa Shoji Holdings's trailing twelve-month P/E ratio is 8.8x, with a price-to-book (P/B) of 1.1x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Koa Shoji Holdings?
Koa Shoji Holdings runs a net profit margin of 15.6%, a gross margin of 33.5%, and an operating margin of 23.2%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Koa Shoji Holdings generate?
Koa Shoji Holdings reported revenue of ¥23.3B for fiscal year 2024, with net income of ¥3.6B and earnings per share (EPS) of 86.38. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Koa Shoji Holdings pay a dividend?
Koa Shoji Holdings offers a trailing dividend yield of about 2.3%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Koa Shoji Holdings financially healthy?
Koa Shoji Holdings carries a debt-to-equity ratio of 0.11x and a current ratio of 4.22x, with a market beta of 0.52. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Koa Shoji Holdings a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Koa Shoji Holdings (9273) the key facts are: market cap ¥32.9B, P/E 8.8x, revenue ¥23.3B, 52-week range 700-919. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Koa Shoji Holdings's full fundamentals live
Get Koa Shoji Holdings's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.